Syneos Health, Inc.
SYNHDelisted Sep 28, 2023- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001610950
Syneos Health, Inc. was delisted on Sep 28, 2023; its insiders filed their last Form 4 on Sep 28, 2023; 317 institutions reported holding it in 13F filings for Q2 2023, worth $4.32B in total; superinvestors Elliott Investment Management and Southeastern Asset Management (Longleaf) held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:42 PM ET
Revenue flow, FY2022
Where the revenue went in FY2022, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 9, 2023 | Feb 17, 2022 | Jan 13, 2021 | Jan 15, 2020 | Mar 18, 2019 |
| Revenue | $5.39B | $5.21B | $4.42B | $4.68B | $4.39B |
| Cost of revenue | $4.14B | $3.99B | $3.40B | – | – |
| Selling, general and administrative | $547.3M | $570.8M | $442.5M | $446.3M | $406.3M |
| Operating income | $403.2M | $389.3M | $293.1M | $237.8M | $160.2M |
| Interest expense | $82.4M | $79.3M | $91.1M | $129.8M | $130.7M |
| Income tax | $48.1M | $80.3M | $10.9M | -$29.5M | $33.0M |
| Net income | $266.5M | $234.8M | $192.8M | $131.3M | $24.3M |
| EPS, basic | $2.59 | $2.26 | $1.85 | $1.27 | $0.23 |
| EPS, diluted | $2.58 | $2.24 | $1.83 | $1.25 | $0.23 |
| Weighted shares, basic | 103.0M | 103.9M | 104.2M | 103.6M | 103.4M |
| Weighted shares, diluted | 103.5M | 105.1M | 105.5M | 105.0M | 104.7M |
| Margins and growth | |||||
| Operating margin | 7.5% | 7.5% | 6.6% | 5.1% | 3.6% |
| Net margin | 4.9% | 4.5% | 4.4% | 2.8% | 0.6% |
| Revenue growth, year over year | +3.5% | +18.1% | −5.6% | +6.5% | +64.3% |
| Net income growth, year over year | +13.5% | +21.8% | +46.9% | +440.5% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 9, 2023 | Feb 17, 2022 | Jan 13, 2021 | Jan 15, 2020 | Mar 18, 2019 |
| Cash and equivalents | – | – | – | – | $153.9M |
| Accounts receivable | – | – | – | $782.3M | $728.6M |
| Total current assets | $1.94B | $1.77B | $1.74B | $1.56B | $1.49B |
| Property, plant and equipment | $264.3M | $222.7M | $216.2M | $203.9M | $183.5M |
| Goodwill | $4.90B | $4.96B | $4.78B | $4.35B | $4.33B |
| Intangible assets | $680.9M | $854.1M | $933.5M | $973.1M | $1.13B |
| Total assets | $8.20B | $8.24B | $8.06B | $7.45B | $7.25B |
| Accounts payable | $118.6M | $107.5M | $113.7M | $136.7M | $98.6M |
| Short-term debt | – | – | – | $58.1M | $50.1M |
| Total current liabilities | $1.72B | $1.65B | $1.58B | $1.52B | $1.50B |
| Long-term debt | $2.61B | $2.78B | $2.90B | $2.55B | $2.74B |
| Total liabilities | $4.70B | $4.82B | $4.82B | $4.42B | $4.40B |
| Shareholders' equity | $3.50B | $3.41B | $3.24B | $3.03B | $2.86B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 9, 2023 | Feb 17, 2022 | Jan 13, 2021 | Jan 15, 2020 | Mar 18, 2019 |
| Operating cash flow | $427.0M | $450.3M | $425.5M | $318.5M | $303.4M |
| Capital expenditures | $93.5M | $56.8M | $50.0M | $64.0M | $54.6M |
| Free cash flow | $333.5M | $393.4M | $375.5M | $254.5M | $248.9M |
| Depreciation and amortization | $247.2M | $235.6M | $222.4M | $242.5M | $273.7M |
| Stock-based compensation | $57.3M | $65.2M | $58.5M | $55.2M | $34.3M |
| Share buybacks | $150.0M | $117.5M | $70.2M | $56.7M | $75.0M |
| Investing cash flow | -$105.6M | -$340.3M | -$504.1M | -$81.7M | -$145.5M |
| Financing cash flow | -$339.2M | -$277.6M | $178.3M | -$215.5M | -$319.4M |
| Net change in cash | $5.53M | -$165.7M | $108.5M | $7.76M | -$166.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.1% | 1.3% | 1.3% | 1.2% | 0.8% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Jul 31, 2023 | 103.7M | +1.0% | SEC |
| May 2, 2023 | 103.6M | +1.0% | SEC |
| Feb 9, 2023 | 103.2M | −0.9% | SEC |
| Oct 31, 2022 | 102.9M | −0.8% | SEC |
| Jul 27, 2022 | 102.7M | −0.8% | SEC |
| Apr 21, 2022 | 102.6M | −1.6% | SEC |
| Feb 10, 2022 | 104.2M | −0.1% | SEC |
| Oct 27, 2021 | 103.7M | −0.3% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.